Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in targeted strategies for triple-negative breast cancer
Shuangli Zhu, Yuze Wu, Bin Song, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 103

Showing 26-50 of 103 citing articles:

Platinum(IV) Complexes Trigger Death Receptors and Natural Killer Cells to Suppress Breast Cancer
Linxiang Cai, Hanhua Chen, Ying Wang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Classifications of triple-negative breast cancer: insights and current therapeutic approaches
Ziqi Chen, Yumeng Liu, Mingzhi Lyu, et al.
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access
Comprehensive characterization of fatty acid oxidation in triple-negative breast cancer: Focus on biological roles and drug modulation
Yunduo Liu, Yanxia Zhang, Qin Xiang, et al.
European Journal of Pharmacology (2025), pp. 177343-177343
Closed Access
Polymer-based nanodrugs enhance sonodynamic therapy through epigenetic reprogramming of the immunosuppressive tumor microenvironment
Lin Yu, Lulu Gao, Bin Liang, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 125-137
Closed Access
Optical-magnetic Imaging for Optimizing Lymphodepletion-TIL Combination Therapy in Breast Cancer
Jiaqian Li, Lishuang Guo, Yuan Feng, et al.
Molecular Imaging and Biology (2025)
Closed Access
Enhanced Cytotoxicity of [10]-Gingerol-Coumarin-Triazole Hybrid as a Theranostic Agent for Triple Negative Breast Cancer
Arthur Deponte Zutião, Bianca Cruz Pachane, Paulo Sérgio Gonçalves Nunes, et al.
ACS Medicinal Chemistry Letters (2025) Vol. 16, Iss. 3, pp. 436-443
Open Access
An update on cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer
Asma Jan, Shazia Sofi, Nusrat Jan, et al.
Future Oncology (2025), pp. 1-21
Closed Access
Triple-Negative Breast Cancer Systemic Treatment: Disruptive Early-Stage Developments for Overcoming Stagnation in the Advanced Pipeline
Carlos Alonso-Ron, Andrea Vethencourt, Eva González‐Suárez, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 633-633
Open Access
Cryo‐Shocked Tumor‐Reprogrammed Sonosensitive Antigen‐Presenting Cells Improving Sonoimmunotherapy via T Cells and NK Cells Immunity
Xindi Qian, Wenzhe Yi, Wenlu Yan, et al.
Advanced Materials (2025)
Closed Access
Intraductal chemotherapy for triple-negative breast cancer: a pathway to minimally invasive clinical treatment
Xinhong Wu, Yuan Feng, Liantao Guo, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Immediate Breast Reconstruction on Overall and Breast Cancer-Specific Survival: A Propensity Score Matched Analysis
Qianrui Xu, Yuntian Wan, Zhangyue Sun, et al.
The Breast (2025) Vol. 80, pp. 104422-104422
Open Access
Instigating Visible Light Inspired DNA Impairment by ROS Harvesting Ir(III)‐Cyclometallated Imidazophenanthroline Complexes Against MDA‐MB‐231 Cells
Sreejani Ghosh, Priyankar Paira
European Journal of Inorganic Chemistry (2025)
Closed Access
Tumor cell-derived EMP1 is essential for cancer-associated fibroblast infiltration in tumor microenvironment of triple-negative breast cancer
Qi Wang, Dandan Li, Haixiu Ma, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Novel clinical potential of poly (ADP‑ribose) polymerase inhibitors in triple‑negative breast cancer: Mechanistic insights and clinical applications (Review)
Han Yu, Lei Wei
Oncology Letters (2025) Vol. 29, Iss. 5, pp. 1-14
Open Access
PKM2 knockout facilitates the activation of the AMPK/KLF4/ACADVL pathway, leading to increased oxidative degradation of fatty acids in TNBC
Linghan Zhang, Cheng Li, Yingchao Ma, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access
BUB1 Inhibition Induces Ferroptosis in Triple-Negative Breast Cancer Cell Lines
Sushmitha Sriramulu, Shivani Thoidingjam, Stephen L. Brown, et al.
DNA (2025) Vol. 5, Iss. 1, pp. 16-16
Open Access
PCK2 promotes invasion and epithelial-to-mesenchymal transition in triple-negative breast cancer by promoting TGF-β/SMAD3 signaling through inhibiting TRIM67-mediated SMAD3 ubiquitination
Tsung‐Ming Chang, Wei-Yu Fang, Hui‐Ping Hsu, et al.
Cancer Biology & Therapy (2025) Vol. 26, Iss. 1
Open Access
Molecular subtyping and target identification in triple negative breast cancer through immunohistochemistry biomarkers
Rima Saad Bouzid, R. Bouzid, Housna Labed, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Modeling and Interpretability Study of the Structure–Activity Relationship for Multigeneration EGFR Inhibitors
Zhiqi Sun, Donghui Huo, Jiangyu Guo, et al.
ACS Omega (2025)
Open Access
Tumor Microenvironment Dynamics of Triple-Negative Breast Cancer Under Radiation Therapy
Suryakant Niture, Subhajit Ghosh, Jerry J. Jaboin, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2795-2795
Open Access
PD-L1 blockade peptide-functionalized NaGdF4 nanodots for efficient magnetic resonance imaging-guided immunotherapy for breast cancer
Zhenzhen Hu, Yunkai Bao, Xiaodong Li, et al.
RSC Advances (2025) Vol. 15, Iss. 12, pp. 9027-9033
Open Access
Reversal of epithelial to mesenchymal transition in triple negative breast cancer through epigenetic modulations by dietary flavonoid Galangin and its combination with SAHA
Snehal Nimal, Navanath Kumbhar, Manasi S. Pote, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Whiteleg shrimp-derived Cryptides induce mitochondrial-mediated cytotoxicity in human breast Cancer
Amr Adel Ahmed Abd El-Aal, Fairen Angelin Jayakumar, Kuan Onn Tan, et al.
Bioorganic Chemistry (2025), pp. 108432-108432
Closed Access
Pharmacokinetics modulation in solid tumors through thrombin-embedded nanomedicine
Lin Sheng, Liuwei Zhang, Hongyan Cui, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Integrated HTS2, UPLC-MS/MS, and network pharmacology identifies Bruceae Fructus waste as potential source of flavonoids and quassinoids for inhibiting breast cancer
Xiankuo Yu, Lei Xiang, Jun An, et al.
Arabian Journal of Chemistry (2025), pp. 1-16
Open Access

Scroll to top